Suchergebnisse - "Buti, Maria"

PubPharm (205)

1

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe

enthalten in: Journal of hepatology | 2024

von Patmore, L. | van Eekhout, K. | Buti, M. | +16

2

Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis : results from the HEBEM study

enthalten in: Journal of neurology | 2024

von Marzo, B. | Vidal-Jordana, A. | Castilló, J. | +6

3

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B

enthalten in: Journal of hepatology | 2024

von Chun, H. | Papatheodoridis, G. | Lee, M. | +23

4

The elimination of hepatitis D as a public health problem : Needs and challenges

enthalten in: Journal of viral hepatitis | 2024

von Vanwolleghem, T. | Armstrong, P. | Buti, M. | +4

5

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

enthalten in: Gastroenterology | 2024

von Sonneveld, M. | Chiu, S. | Park, J. | +26

6

In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments

enthalten in: International journal of molecular sciences | 2023

von Colomer-Castell, S. | Gregori, J. | Garcia-Cehic, D. | +12

7

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D : Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Ghany, M. | Buti, M. | Lampertico, P. | +2

8

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

enthalten in: Gastroenterologia y hepatologia | 2023

von Martínez-Campreciós, J. | Riveiro-Barciela, M. | Muñoz-Gómez, R. | +19

9

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis : a REAL-C study

enthalten in: Hepatology international | 2023

von Wong, Y. | Tran, S. | Huang, C. | +81

10

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]